Drug Profile
Hepatitis B DNA vaccine - Guangzhou Baidi Biotechnology
Alternative Names: double-plasmid HBV DNA vaccine - Guangzhou Baidi BiotechnologyLatest Information Update: 27 Feb 2019
Price :
$50
*
At a glance
- Originator Guangzhou Baidi Biotechnology
- Developer Guangzhou Baidi Biotechnology; Guangzhou Pharmaceutical
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 27 Feb 2019 Discontinued - Phase-II for Hepatitis B (Combination therapy) in China (IM)